The Global Multi-Omics Market which largely consists of Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness double digit growth. The demand for personalised medicine, technical developments, a favourable funding environment, the increased prevalence of cancer and genetic disorders, and expanding pharmaceutical and biotech R&D expenditure are projected to be the main drivers of the next phase of growth.